Cash flow Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 16:00:02 2024-12-10 EST			5-day change	1st Jan Change
246.19 ^USD	+0.08%		+8.23%	+27.88%

12-06	Veeva Systems Insider Sold Shares Worth $390,128, According to a Recent SEC Filing	MT
12-06	KeyBanc Raises Veeva Systems Price Target to $285 From $240, Maintains Overweight Rating	MT

4e67ba55822348eb1e93.kzkcLrjTLcpay82lDSXKpE3DPr9ADMTgjMkZh7bNYWk.9kBsbPqYTrMLuvjyR1CN5h61TY0oeomQ-75o0viFBw7KVkp-gYtMoWqyiA

Published financial data: VEEVA SYSTEMS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2020	2021	2022	2023	2024
Revenues	1.1B	1.47B	1.85B	2.16B	2.36B
Total Revenues	1.1B	1.47B	1.85B	2.16B	2.36B
Cost of Goods Sold, Total	303M	409M	504M	609M	677M
Gross Profit	801M	1.06B	1.35B	1.55B	1.69B
Selling General & Admin Expenses, Total	303M	384M	460M	566M	628M
R&D Expenses	210M	294M	382M	520M	629M
Other Operating Expenses, Total	513M	678M	842M	1.09B	1.26B
Operating Income	288M	378M	505M	459M	429M
Interest And Investment Income	25.18M	15.86M	14.73M	45.86M	134M
Net Interest Expenses	25.18M	15.86M	14.73M	45.86M	134M
Currency Exchange Gains (Loss)	-708K	2.28M	-714K	591K	124K
Other Non Operating Income (Expenses)	-	1.15M	-	572K	-
EBT, Excl. Unusual Items	312M	397M	520M	506M	563M
Merger & Related Restructuring Charges	-1.3M	-	-	-	-
Gain (Loss) On Sale Of Investments	3M	-3.08M	-7.2M	2.98M	24.82M
EBT, Incl. Unusual Items	314M	394M	512M	509M	588M
Income Tax Expense	12.58M	14M	84.92M	21.39M	62.32M
Earnings From Continuing Operations	301M	380M	427M	488M	526M
Net Income to Company	301M	380M	427M	488M	526M
Net Income - (IS)	301M	380M	427M	488M	526M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	301M	380M	427M	488M	526M
Net Income to Common Excl. Extra Items	301M	380M	427M	488M	526M
Per Share Items
Net EPS - Basic	2.04	2.52	2.79	3.14	3.27
Basic EPS - Continuing Operations	2.04	2.52	2.79	3.14	3.27
Basic Weighted Average Shares Outstanding	148M	151M	153M	155M	161M
Net EPS - Diluted	1.9	2.36	2.63	3	3.22
Diluted EPS - Continuing Operations	1.9	2.36	2.63	3	3.22
Diluted Weighted Average Shares Outstanding	158M	161M	162M	162M	163M
Normalized Basic EPS	1.32	1.65	2.12	2.04	2.19
Normalized Diluted EPS	1.23	1.54	2	1.95	2.15
Supplemental Items
EBITDA	307M	407M	533M	488M	462M
EBITA	298M	398M	524M	478M	448M
EBIT	288M	378M	505M	459M	429M
EBITDAR	316M	420M	547M	504M	478M
Total Revenues (As Reported)	1.1B	1.47B	1.85B	2.16B	2.36B
Effective Tax Rate - (Ratio)	4.01	3.55	16.58	4.2	10.6
Current Domestic Taxes	15.84M	11.87M	66.01M	140M	156M
Current Foreign Taxes	3.4M	2.82M	7.84M	8.51M	12.16M
Total Current Taxes	19.24M	14.7M	73.84M	149M	168M
Deferred Domestic Taxes	-1.58M	-135K	2.82M	-120M	-103M
Deferred Foreign Taxes	-5.08M	-566K	8.26M	-7.82M	-1.98M
Total Deferred Taxes	-6.66M	-701K	11.08M	-128M	-105M
Normalized Net Income	195M	248M	325M	316M	352M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	190M	235M	288M	349M	381M
General and Administrative Expenses	113M	149M	172M	218M	247M
Research And Development Expense From Footnotes	210M	294M	382M	520M	629M
Net Rental Expense, Total	8.3M	13M	14M	16M	16M
Stock-Based Comp., COGS (Total)	20.16M	32.54M	41.09M	56.6M	59.72M
Stock-Based Comp., R&D Exp. (Total)	37M	63.54M	83.84M	142M	173M
Stock-Based Comp., S&M Exp. (Total)	27.54M	40.57M	56.83M	87.51M	90.86M
Stock-Based Comp., G&A Exp. (Total)	31.21M	48.35M	52.88M	66.23M	70.27M
Total Stock-Based Compensation	116M	185M	235M	352M	394M

Fiscal Period: January	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	477M	731M	1.14B	886M	703M
Short Term Investments	610M	933M	1.24B	2.22B	3.32B
Total Cash And Short Term Investments	1.09B	1.66B	2.38B	3.1B	4.03B
Accounts Receivable, Total	423M	612M	694M	785M	889M
Total Receivables	423M	612M	694M	785M	889M
Prepaid Expenses	21.79M	35.17M	35.46M	81.46M	86.92M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	75K	440K	1.22M	-	-
Total Current Assets	1.53B	2.31B	3.11B	3.97B	5B
Gross Property Plant And Equipment	137M	140M	134M	137M	141M
Accumulated Depreciation	-33.32M	-29.62M	-30.27M	-32.12M	-36.76M
Net Property Plant And Equipment	104M	111M	104M	105M	104M
Goodwill	439M	436M	440M	440M	440M
Other Intangibles, Total	135M	115M	102M	82.48M	63.02M
Deferred Tax Assets Long-Term	11.87M	14.1M	5.1M	137M	233M
Deferred Charges Long-Term	35.58M	42.07M	33.11M	31.82M	23.92M
Other Long-Term Assets, Total	16.18M	17.88M	25.13M	38.96M	43.3M
Total Assets	2.27B	3.05B	3.82B	4.8B	5.91B
Liabilities
Accounts Payable, Total	19.42M	23.25M	20.35M	41.68M	31.51M
Accrued Expenses, Total	47.24M	61.39M	69.94M	79.59M	76.41M
Current Portion of Leases	10.01M	11.72M	10.98M	11.31M	9.33M
Current Income Taxes Payable	5.61M	2.59M	7.76M	4.95M	11.86M
Unearned Revenue Current, Total	469M	617M	732M	869M	1.05B
Total Current Liabilities	551M	716M	841M	1.01B	1.18B
Long-Term Leases	44.82M	51.39M	43.61M	49.67M	46.44M
Deferred Tax Liability Non Current	2.42M	1.84M	2.22M	1.49M	2.05M
Other Non Current Liabilities	7.78M	10.57M	18.23M	30.08M	38.72M
Total Liabilities	606M	780M	905M	1.09B	1.27B
Common Stock, Total	1K	2K	2K	2K	2K
Additional Paid In Capital	745M	966M	1.2B	1.53B	1.92B
Retained Earnings	920M	1.3B	1.73B	2.21B	2.74B
Comprehensive Income and Other	460K	992K	-11.96M	-31.13M	-10.64M
Total Common Equity	1.67B	2.27B	2.91B	3.72B	4.64B
Total Equity	1.67B	2.27B	2.91B	3.72B	4.64B
Total Liabilities And Equity	2.27B	3.05B	3.82B	4.8B	5.91B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	149M	152M	154M	160M	161M
ECS Total Common Shares Outstanding	149M	152M	154M	158M	161M
Book Value / Share	11.17	14.9	18.88	23.48	28.8
Tangible Book Value	1.09B	1.72B	2.37B	3.19B	4.14B
Tangible Book Value Per Share	7.33	11.28	15.37	20.18	25.68
Total Debt	54.83M	63.12M	54.59M	60.98M	55.78M
Net Debt	-1.03B	-1.6B	-2.32B	-3.04B	-3.97B
Debt Equivalent Oper. Leases	66.4M	104M	112M	128M	128M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	3.04M	3.04M	3.04M	3.04M	3.04M
Buildings, Total	20.98M	20.98M	20.98M	20.98M	20.98M
Machinery, Total	23.92M	22.3M	18.62M	16.23M	18.05M
Full Time Employees	3.5K	4.51K	5.48K	6.74K	7.17K
Accumulated Allowance for Doubtful Accounts (Supple)	617K	193K	473K	469K	520K

Fiscal Period: January	2020	2021	2022	2023	2024
Net Income	301M	380M	427M	488M	526M
Depreciation & Amortization - CF	9.76M	9.46M	8.45M	10.12M	13.63M
Amortization of Goodwill and Intangible Assets - (CF)	10.1M	20M	19M	19M	19M
Depreciation & Amortization, Total	19.86M	29.46M	27.45M	29.12M	32.63M
Amortization of Deferred Charges, Total - (CF)	20.52M	20.68M	26.05M	22.1M	18.18M
(Gain) Loss on Sale of Investments - (CF)	-3.27M	3.13M	6.26M	-3.62M	-26.52M
Stock-Based Compensation (CF)	116M	185M	235M	352M	394M
Provision and Write-off of Bad Debts	244K	-307K	272K	256K	693K
Other Operating Activities, Total	1.18M	8.93M	21.74M	-114M	-93.9M
Change In Accounts Receivable	-70.09M	-188M	-83.08M	-91.08M	-104M
Change In Accounts Payable	2.81M	754K	-3M	21.43M	-10.23M
Change in Unearned Revenues	97.75M	147M	116M	140M	188M
Change In Income Taxes	1.13M	-3.02M	5.28M	-2.82M	6.92M
Change in Other Net Operating Assets	-49.79M	-32.4M	-14.68M	-60.66M	-20.03M
Cash from Operations	437M	551M	764M	780M	911M
Capital Expenditure	-3.11M	-8.68M	-14.21M	-13.51M	-26.2M
Cash Acquisitions	-448M	-	-7.78M	-	-
Sale (Purchase) of Intangible assets	-1.21M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-64.43M	-325M	-324M	-994M	-1.05B
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-517M	-334M	-346M	-1.01B	-1.08B
Long-Term Debt Repaid, Total	-984K	-1.04M	-384K	-	-
Total Debt Repaid	-984K	-1.04M	-384K	-	-
Issuance of Common Stock	10.99M	34.86M	51.54M	43.65M	62.69M
Repurchase of Common Stock	-	-	-55.29M	-63.03M	-78.88M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	10.01M	33.82M	-4.14M	-19.38M	-16.19M
Foreign Exchange Rate Adjustments	-2.86M	484K	-4.66M	-4.99M	-1.78M
Net Change in Cash	-72.38M	252M	410M	-252M	-183M
Supplemental Items
Cash Income Tax Paid (Refund)	14.29M	18.1M	58.63M	168M	134M
Levered Free Cash Flow	371M	423M	632M	707M	752M
Unlevered Free Cash Flow	371M	423M	632M	707M	752M
Change In Net Working Capital	-39.01M	39.76M	-41.69M	-30.09M	-65.28M
Net Debt Issued / Repaid	-984K	-1.04M	-384K	-	-

Fiscal Period: January	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.16	8.88	9.21	6.66	5.01
Return on Total Capital	12.15	11.66	11.93	8.51	6.33
Return On Equity %	20.74	19.33	16.51	14.72	12.58
Return on Common Equity	20.74	19.33	16.51	14.72	12.58
Margin Analysis
Gross Profit Margin %	72.52	72.09	72.79	71.72	71.35
SG&A Margin	27.47	26.22	24.83	26.28	26.57
EBITDA Margin %	27.84	27.8	28.8	22.65	19.54
EBITA Margin %	26.96	27.15	28.34	22.18	18.97
EBIT Margin %	26.04	25.79	27.31	21.3	18.16
Income From Continuing Operations Margin %	27.27	25.94	23.09	22.63	22.24
Net Income Margin %	27.27	25.94	23.09	22.63	22.24
Net Avail. For Common Margin %	27.27	25.94	23.09	22.63	22.24
Normalized Net Income Margin	17.66	16.94	17.54	14.68	14.89
Levered Free Cash Flow Margin	33.57	28.86	34.12	32.79	31.81
Unlevered Free Cash Flow Margin	33.57	28.86	34.12	32.79	31.81
Asset Turnover
Asset Turnover	0.56	0.55	0.54	0.5	0.44
Fixed Assets Turnover	13.9	13.66	17.24	20.59	22.59
Receivables Turnover (Average Receivables)	2.97	2.83	2.83	2.91	2.82
Short Term Liquidity
Current Ratio	2.78	3.23	3.7	3.94	4.24
Quick Ratio	2.74	3.18	3.65	3.86	4.17
Operating Cash Flow to Current Liabilities	0.79	0.77	0.91	0.78	0.77
Days Sales Outstanding (Average Receivables)	123	129.17	128.78	125.3	129.23
Average Days Payable Outstanding	17.16	19.1	15.8	18.57	19.72
Long Term Solvency
Total Debt/Equity	3.29	2.78	1.87	1.64	1.2
Total Debt / Total Capital	3.19	2.71	1.84	1.61	1.19
LT Debt/Equity	2.69	2.27	1.5	1.34	1
Long-Term Debt / Total Capital	2.6	2.21	1.47	1.31	0.99
Total Liabilities / Total Assets	26.68	25.6	23.71	22.65	21.42
Total Debt / EBITDA	0.17	0.15	0.1	0.12	0.12
Net Debt / EBITDA	-3.27	-3.81	-4.24	-6.03	-8.31
Total Debt / (EBITDA - Capex)	0.18	0.15	0.1	0.12	0.12
Net Debt / (EBITDA - Capex)	-3.3	-3.89	-4.36	-6.2	-8.79
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	28.05	32.7	26.33	16.44	9.68
Gross Profit, 1 Yr. Growth %	29.79	31.9	27.55	14.74	9.1
EBITDA, 1 Yr. Growth %	29.73	33.05	30.86	-8.39	-5.38
EBITA, 1 Yr. Growth %	29.47	34.29	31.85	-8.85	-6.22
EBIT, 1 Yr. Growth %	29.01	31.99	33.8	-9.18	-6.48
Earnings From Cont. Operations, 1 Yr. Growth %	31.02	26.2	12.47	14.11	7.79
Net Income, 1 Yr. Growth %	31.02	26.2	12.47	14.11	7.79
Normalized Net Income, 1 Yr. Growth %	32.12	27.8	30.83	-2.58	11.28
Diluted EPS Before Extra, 1 Yr. Growth %	29.25	24.21	11.44	14.07	7.33
Accounts Receivable, 1 Yr. Growth %	31.38	44.75	13.54	13.08	13.16
Net Property, Plant and Equip., 1 Yr. Growth %	89	6.43	-5.82	0.98	-0.97
Total Assets, 1 Yr. Growth %	37.37	34.08	25.29	25.88	23.03
Tangible Book Value, 1 Yr. Growth %	-2.23	57.05	38.13	34.77	29.68
Common Equity, 1 Yr. Growth %	34.57	36.07	28.47	27.63	24.99
Cash From Operations, 1 Yr. Growth %	40.71	26.04	38.68	2.09	16.77
Capital Expenditures, 1 Yr. Growth %	-63.12	100.95	63.7	-4.94	93.87
Levered Free Cash Flow, 1 Yr. Growth %	54.19	14.32	49.37	11.89	6.41
Unlevered Free Cash Flow, 1 Yr. Growth %	54.19	14.32	49.37	11.89	6.41
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	26.44	30.35	29.47	21.28	13.01
Gross Profit, 2 Yr. CAGR %	29.27	30.84	29.71	20.97	11.89
EBITDA, 2 Yr. CAGR %	33.6	31.1	31.95	9.49	-6.9
EBITA, 2 Yr. CAGR %	34.01	31.55	33.07	9.63	-7.55
EBIT, 2 Yr. CAGR %	34.93	30.2	32.9	10.24	-7.84
Earnings From Cont. Operations, 2 Yr. CAGR %	41.13	28.58	19.14	13.29	10.91
Net Income, 2 Yr. CAGR %	41.13	28.58	19.14	13.29	10.91
Normalized Net Income, 2 Yr. CAGR %	36.48	29.67	29.31	12.9	4.12
Diluted EPS Before Extra, 2 Yr. CAGR %	39.24	26.71	17.65	12.75	10.65
Accounts Receivable, 2 Yr. CAGR %